Bo Pang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bo Pang has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Younan Xia
School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
7 shared publications Miaoxin Yang
4 shared publicationsQiushi Ren
Department of Biomedical Engineering, College of Engineering, Peking University , Beijing 100871, P. R. China
4 shared publicationsTianmeng Sun
The Wallace H. Coulter Department of Biomedical Engineering Georgia Institute of Technology and Emory University Atlanta GA 30332 USA
4 shared publications- Xuan Yang
Huazhong University of Science and Technology
4 shared publications Younan Xia
The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA
4 shared publications
Latest Publications
- 1 September 2017
- Published by Trans Tech Publications, Ltd. in Journal of Nano Research
- Vol. 49, 85-97
Large-Scale High-Yield Synthesis of PdCu@Au Tripods and the Quantification of their Luminescence Properties for Cancer Cell Imaging
The synthesis of anisotropic branched gold nanoparticles remines to be challenging as their arm number and arm length could hardly be controlled, greatly limited their biomedical application. We report the large-scale high-yield synthesis of PdCu@Au tripods, and, for the first time, their two-photon luminescence properties with quantitative characterization of the two-photon action cross section as well as quantum yield. By introducing nitrogen protection to the synthesis of the PdCu bimetallic cores, this approach eliminates the oxidative etching caused by oxygen in the air, providing a 2.5 times higher synthetic yield of 70.4 %, which enables the large-scale preparation of PdCu@Au at ca. 380 mg per batch. By the conformal coating of PdCu bimetallic cores, the PdCu@Au tripods are prepared with a purity of >90 % with average arm length 45.3 ± 5.6 nm that is ideal for biomedical applications. The PdCu@Au tripods demonstrate a much brighter two-photon luminescence than that from Au nanorods, with a 3.6 ± 0.9 times larger two-photon action cross section and comparable quantum yield. Our result also shows the two-photon luminescence property of PdCu@Au tripods could be tuned by their distinct localized surface plasmon resonance property and, in turn, the different amount of Au coating. This tunability could be explained by the recently-proposed two-step excitation mechanism of two-photon luminescence in Au nanoparticle. The folate-targeted in vitro two-photon luminescence imaging of MDA-MB-435 breast cancer cells were also demonstrated to show the great potential using PdCu@Au tripods as novel multi-functional platforms for cancer theranostics.
- 1 September 2017
- Published by Trans Tech Publications, Ltd. in Journal of Nano Research
- Vol. 49, 85-97
Large-Scale High-Yield Synthesis of PdCu@Au Tripods and the Quantification of their Luminescence Properties for Cancer Cell Imaging
The synthesis of anisotropic branched gold nanoparticles remines to be challenging as their arm number and arm length could hardly be controlled, greatly limited their biomedical application. We report the large-scale high-yield synthesis of PdCu@Au tripods, and, for the first time, their two-photon luminescence properties with quantitative characterization of the two-photon action cross section as well as quantum yield. By introducing nitrogen protection to the synthesis of the PdCu bimetallic cores, this approach eliminates the oxidative etching caused by oxygen in the air, providing a 2.5 times higher synthetic yield of 70.4 %, which enables the large-scale preparation of PdCu@Au at ca. 380 mg per batch. By the conformal coating of PdCu bimetallic cores, the PdCu@Au tripods are prepared with a purity of >90 % with average arm length 45.3 ± 5.6 nm that is ideal for biomedical applications. The PdCu@Au tripods demonstrate a much brighter two-photon luminescence than that from Au nanorods, with a 3.6 ± 0.9 times larger two-photon action cross section and comparable quantum yield. Our result also shows the two-photon luminescence property of PdCu@Au tripods could be tuned by their distinct localized surface plasmon resonance property and, in turn, the different amount of Au coating. This tunability could be explained by the recently-proposed two-step excitation mechanism of two-photon luminescence in Au nanoparticle. The folate-targeted in vitro two-photon luminescence imaging of MDA-MB-435 breast cancer cells were also demonstrated to show the great potential using PdCu@Au tripods as novel multi-functional platforms for cancer theranostics.
- 2 September 2016
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 8 (45) , 18912-18920
Dynamic visualization of photothermal heating by gold nanocages using thermoresponsive elastin like polypeptides
Understanding how plasmonic nanoparticles collectively generate heat upon exposure to light and thus increase the local temperature of the surrounding medium is critical for many applications such as plasmon-assisted microfluidics, plasmonic tweezers, and photothermal cancer therapy. Reliable temperature manipulation requires the capability to spatially and dynamically analyze local temperature profiles as a function of nanoparticle concentration and laser intensity. In this work, we present a novel method for visualization of local temperature increase using elastin-like polypeptides (ELP). We also propose a robust algorithm that allows the construction of reliable calibration curves using known boundary conditions and Boltzmann sigmoid fit applied to the ELP solution's temperature-absorption transfer function. Using this technique, for the first time, we successfully demonstrated how surface and volume distribution of the nano-heaters affect collective heat generation. This approach allows the visualization of dynamic 2D-temperature profiles and simultaneously enables the measurement of specific temperature at any point in a 2D-map. The experimental setup is compatible with conventional optical microscopy and requires no specialized hardware or complex sample preparation. Finally, the real time visualization of plasmonic heating offers an opportunity to control outcomes of thermo-plasmonics which enables a myriad of practical applications.
- 2 September 2016
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 8 (45) , 18912-18920
Dynamic visualization of photothermal heating by gold nanocages using thermoresponsive elastin like polypeptides
Understanding how plasmonic nanoparticles collectively generate heat upon exposure to light and thus increase the local temperature of the surrounding medium is critical for many applications such as plasmon-assisted microfluidics, plasmonic tweezers, and photothermal cancer therapy. Reliable temperature manipulation requires the capability to spatially and dynamically analyze local temperature profiles as a function of nanoparticle concentration and laser intensity. In this work, we present a novel method for visualization of local temperature increase using elastin-like polypeptides (ELP). We also propose a robust algorithm that allows the construction of reliable calibration curves using known boundary conditions and Boltzmann sigmoid fit applied to the ELP solution's temperature-absorption transfer function. Using this technique, for the first time, we successfully demonstrated how surface and volume distribution of the nano-heaters affect collective heat generation. This approach allows the visualization of dynamic 2D-temperature profiles and simultaneously enables the measurement of specific temperature at any point in a 2D-map. The experimental setup is compatible with conventional optical microscopy and requires no specialized hardware or complex sample preparation. Finally, the real time visualization of plasmonic heating offers an opportunity to control outcomes of thermo-plasmonics which enables a myriad of practical applications.
- 27 June 2016
- Published by Taylor & Francis in Nanomedicine
- Vol. 11 (13) , 1715-1728
Putting Gold Nanocages to Work For Optical Imaging, Controlled Release and Cancer Theranostics
Gold nanocages are hollow nanostructures with ultrathin, porous walls. They are bio-inert and their surface can be readily modified with functional groups to specifically interact with the biological system of interest. They have remarkable optical properties, including localized surface plasmon resonance peaks tunable to the near-infrared region, strong absorption and scattering, as well as two- and three-photon luminescence. With the establishment of robust protocols for both synthesis and surface functionalization, Au nanocages have been extensively explored for various biomedical applications. In this review, we begin with a brief account of the synthesis and properties of Au nanocages, and then highlight some of the recent developments in applying them to an array of biomedical applications related to optical imaging, controlled release and cancer theranostics.
- 27 June 2016
- Published by Taylor & Francis in Nanomedicine
- Vol. 11 (13) , 1715-1728
Putting Gold Nanocages to Work For Optical Imaging, Controlled Release and Cancer Theranostics
Gold nanocages are hollow nanostructures with ultrathin, porous walls. They are bio-inert and their surface can be readily modified with functional groups to specifically interact with the biological system of interest. They have remarkable optical properties, including localized surface plasmon resonance peaks tunable to the near-infrared region, strong absorption and scattering, as well as two- and three-photon luminescence. With the establishment of robust protocols for both synthesis and surface functionalization, Au nanocages have been extensively explored for various biomedical applications. In this review, we begin with a brief account of the synthesis and properties of Au nanocages, and then highlight some of the recent developments in applying them to an array of biomedical applications related to optical imaging, controlled release and cancer theranostics.
- 18 March 2016
- Published by Wiley in Chemnanomat
- Vol. 2 (5) , 400-406
Targeted Delivery of Anti‐miR‐712 by VCAM1‐Binding Au Nanospheres for Atherosclerosis Therapy
Atherosclerosis is a chronic, inflammatory disease of the vascular wall, which preferentially develops in regions under disturbed flow (d‐flow). Once inflamed, the endothelial cells initiate a signaling cascade that culminates in the expression of pro‐atherogenic genes such as mRNAs and miRNAs. Here we demonstrate that vascular cell adhesion molecule 1 (VCAM1), which is highly expressed on the surface of endothelial cells under d‐flow, can serve as a marker for the targeted delivery of drug to the inflamed endothelium. We could selectively deliver anti‐miR‐712, an inhibitor of a key pro‐atherogenic miRNA, to VCAM1‐expressing immortalized mouse aortic endothelial cells (iMAECs) by hybridizing the inhibitor with a carrier DNA that has a complementary sequence and is conjugated to the surface of Au nanospheres. Our results suggest that the combination of VCAM1‐binding peptide and Au nanosphere could provide an effective strategy for the selective delivery of anti‐athero‐miRNAs or other drugs into inflamed endothelium for the purpose of inhibiting the formation of atherosclerotic plaques.
- 18 March 2016
- Published by Wiley in Chemnanomat
- Vol. 2 (5) , 400-406
Targeted Delivery of Anti‐miR‐712 by VCAM1‐Binding Au Nanospheres for Atherosclerosis Therapy
Atherosclerosis is a chronic, inflammatory disease of the vascular wall, which preferentially develops in regions under disturbed flow (d‐flow). Once inflamed, the endothelial cells initiate a signaling cascade that culminates in the expression of pro‐atherogenic genes such as mRNAs and miRNAs. Here we demonstrate that vascular cell adhesion molecule 1 (VCAM1), which is highly expressed on the surface of endothelial cells under d‐flow, can serve as a marker for the targeted delivery of drug to the inflamed endothelium. We could selectively deliver anti‐miR‐712, an inhibitor of a key pro‐atherogenic miRNA, to VCAM1‐expressing immortalized mouse aortic endothelial cells (iMAECs) by hybridizing the inhibitor with a carrier DNA that has a complementary sequence and is conjugated to the surface of Au nanospheres. Our results suggest that the combination of VCAM1‐binding peptide and Au nanosphere could provide an effective strategy for the selective delivery of anti‐athero‐miRNAs or other drugs into inflamed endothelium for the purpose of inhibiting the formation of atherosclerotic plaques.
- 10 February 2016
- Published by Wiley in Advanced Healthcare Materials
- Vol. 5 (8) , 928-935
Gold Nanoparticles Doped with 199Au Atoms and Their Use for Targeted Cancer Imaging by SPECT
Gold nanoparticles have been labeled with various radionuclides and extensively explored for single photon emission computed tomography (SPECT) in the context of cancer diagnosis. The stability of most radiolabels, however, still needs to be improved for accurate detection of cancer biomarkers and thereby monitoring of tumor progression and metastasis. Here, the first synthesis of Au nanoparticles doped with 199Au atoms for targeted SPECT tumor imaging in a mouse triple negative breast cancer (TNBC) model is reported. By directly incorporating 199Au atoms into the crystal lattice of each Au nanoparticle, the stability of the radiolabel can be ensured. The synthetic procedure also allows for a precise control over both the radiochemistry and particle size. When conjugated with D‐Ala1‐peptide T‐amide, the Au nanoparticles doped with 199Au atoms can serve as a C‐C chemokine receptor 5 (CCR5)‐targeted nanoprobe for the sensitive and specific detection of both TNBC and its metastasis in a mouse tumor model.
- 10 February 2016
- Published by Wiley in Advanced Healthcare Materials
- Vol. 5 (8) , 928-935
Gold Nanoparticles Doped with 199Au Atoms and Their Use for Targeted Cancer Imaging by SPECT
Gold nanoparticles have been labeled with various radionuclides and extensively explored for single photon emission computed tomography (SPECT) in the context of cancer diagnosis. The stability of most radiolabels, however, still needs to be improved for accurate detection of cancer biomarkers and thereby monitoring of tumor progression and metastasis. Here, the first synthesis of Au nanoparticles doped with 199Au atoms for targeted SPECT tumor imaging in a mouse triple negative breast cancer (TNBC) model is reported. By directly incorporating 199Au atoms into the crystal lattice of each Au nanoparticle, the stability of the radiolabel can be ensured. The synthetic procedure also allows for a precise control over both the radiochemistry and particle size. When conjugated with D‐Ala1‐peptide T‐amide, the Au nanoparticles doped with 199Au atoms can serve as a C‐C chemokine receptor 5 (CCR5)‐targeted nanoprobe for the sensitive and specific detection of both TNBC and its metastasis in a mouse tumor model.
- 2 February 2016
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 10 (3) , 3121-3131
64Cu-Doped PdCu@Au Tripods: A Multifunctional Nanomaterial for Positron Emission Tomography and Image-Guided Photothermal Cancer Treatment
This article reports a facile synthesis of radiolabeled PdCu@Au core–shell tripods for use in positron emission tomography (PET) and image-guided photothermal cancer treatment by directly incorporating radioactive 64Cu atoms into the crystal lattice. The tripod had a unique morphology determined by the PdCu tripod that served as a template for the coating of Au shell, in addition to well-controlled specific activity and physical dimensions. The Au shell provided the nanostructure with strong absorption in the near-infrared region and effectively prevented the Cu and 64Cu atoms in the core from oxidization and dissolution. When conjugated with d-Ala1-peptide T-amide (DAPTA), the core–shell tripods showed great enhancement in targeting the C–C chemokine receptor 5 (CCR5), a newly identified theranostic target up-regulated in triple negative breast cancer (TNBC). Specifically, the CCR5-targeted tripods with an arm length of about 45 nm showed 2- and 6-fold increase in tumor-to-blood and tumor-to-muscle uptake ratios, respectively, relative to their nontargeted counterpart in an orthotopic mouse 4T1 TNBC model at 24 h postinjection. The targeting specificity was further validated via a competitive receptor blocking study. We also demonstrated the use of these targeted, radioactive tripods for effective photothermal treatment in the 4T1 tumor model as guided by PET imaging. The efficacy of treatment was confirmed by the significant reduction in tumor metabolic activity revealed through the use of 18F-fluorodeoxyglucose PET/CT imaging. Taken together, we believe that the 64Cu-doped PdCu@Au tripods could serve as a multifunctional platform for both PET imaging and image-guided photothermal cancer therapy.
- 2 February 2016
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 10 (3) , 3121-3131
64Cu-Doped PdCu@Au Tripods: A Multifunctional Nanomaterial for Positron Emission Tomography and Image-Guided Photothermal Cancer Treatment
This article reports a facile synthesis of radiolabeled PdCu@Au core–shell tripods for use in positron emission tomography (PET) and image-guided photothermal cancer treatment by directly incorporating radioactive 64Cu atoms into the crystal lattice. The tripod had a unique morphology determined by the PdCu tripod that served as a template for the coating of Au shell, in addition to well-controlled specific activity and physical dimensions. The Au shell provided the nanostructure with strong absorption in the near-infrared region and effectively prevented the Cu and 64Cu atoms in the core from oxidization and dissolution. When conjugated with d-Ala1-peptide T-amide (DAPTA), the core–shell tripods showed great enhancement in targeting the C–C chemokine receptor 5 (CCR5), a newly identified theranostic target up-regulated in triple negative breast cancer (TNBC). Specifically, the CCR5-targeted tripods with an arm length of about 45 nm showed 2- and 6-fold increase in tumor-to-blood and tumor-to-muscle uptake ratios, respectively, relative to their nontargeted counterpart in an orthotopic mouse 4T1 TNBC model at 24 h postinjection. The targeting specificity was further validated via a competitive receptor blocking study. We also demonstrated the use of these targeted, radioactive tripods for effective photothermal treatment in the 4T1 tumor model as guided by PET imaging. The efficacy of treatment was confirmed by the significant reduction in tumor metabolic activity revealed through the use of 18F-fluorodeoxyglucose PET/CT imaging. Taken together, we believe that the 64Cu-doped PdCu@Au tripods could serve as a multifunctional platform for both PET imaging and image-guided photothermal cancer therapy.
- 21 August 2015
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 115 (19) , 10410-10488
Gold Nanomaterials at Work in Biomedicine
- 21 August 2015
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 115 (19) , 10410-10488
Gold Nanomaterials at Work in Biomedicine
- Open Access
- 1 February 2015
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 10, 1307-1320
Interstitial diffuse radiance spectroscopy of gold nanocages and nanorods in bulk muscle tissues
Interstitial diffuse radiance spectroscopy of gold nanocages and nanorods in bulk muscle tissues Serge Grabtchak,1,2 Logan G Montgomery,1 Bo Pang,3,4 Yi Wang,4,5 Chao Zhang,6,7 Zhiyuan Li,6,7 Younan Xia,4,8 William M Whelan1,91Department of Physics, University of Prince Edward Island, Charlottetown, PEI, Canada; 2Departments of Electrical and Computer Engineering, and Physics, Dalhousie University, Halifax, Canada; 3Department of Biomedical Engineering, Peking University, Beijing, People’s Republic of China; 4The Wallace H Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; 5Key Laboratory of Green Synthesis and Applications, College of Chemistry, Chongqing Normal University, Chongqing, People’s Republic of China; 6Laboratory of Optical Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, People’s Republic of China; 7College of Physics and Optoelectronics, South China University of Technology, Guangzhou, People’s Republic of China; 8School of Chemistry and Biochemistry, and School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA; 9Atlantic Veterinary College, Charlottetown, PEI, Canada Radiance spectroscopy was applied to the interstitial detection of localized inclusions containing Au nanocages or nanorods with various concentrations embedded in porcine muscle phantoms. The radiance was quantified using a perturbation approach, which enabled the separation of contributions from the porcine phantom and the localized inclusion, with the inclusion serving as a perturbation probe of photon distributions in the turbid medium. Positioning the inclusion at various places in the phantom allowed for tracking of photons that originated from a light source, passed through the inclusion’s location, and reached a detector. The inclusions with high extinction coefficients were able to absorb nearly all photons in the range of 650–900 nm, leading to a spectrally flat radiance signal. This signal could be converted to the relative density of photons incident on the inclusion. Finally, the experimentally measured quantities were expressed via the relative perturbation and arranged into the classical Beer–Lambert law that allowed one to extract the extinction coefficients of various types of Au nanoparticles in both the transmission and back reflection geometries. It was shown that the spatial variation of perturbation could be described as 1/r dependence, where r is the distance between the inclusion and the detector. Due to a larger absorption cross section, Au nanocages produced greater perturbations than Au nanorods of equal particle concentration, indicating a better suitability of Au nanocages as contrast agents for optical measurements in turbid media. Individual measurements from different inclusions were combined into detectability maps.Keywords: gold nanocages, gold nanorods, turbid media, porcine muscles, diffuse radiance spectroscopy, Beer–Lambert law, perturbation
- 1 February 2015
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 10, 1307-1320
Open AccessInterstitial diffuse radiance spectroscopy of gold nanocages and nanorods in bulk muscle tissues
Interstitial diffuse radiance spectroscopy of gold nanocages and nanorods in bulk muscle tissues Serge Grabtchak,1,2 Logan G Montgomery,1 Bo Pang,3,4 Yi Wang,4,5 Chao Zhang,6,7 Zhiyuan Li,6,7 Younan Xia,4,8 William M Whelan1,91Department of Physics, University of Prince Edward Island, Charlottetown, PEI, Canada; 2Departments of Electrical and Computer Engineering, and Physics, Dalhousie University, Halifax, Canada; 3Department of Biomedical Engineering, Peking University, Beijing, People’s Republic of China; 4The Wallace H Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; 5Key Laboratory of Green Synthesis and Applications, College of Chemistry, Chongqing Normal University, Chongqing, People’s Republic of China; 6Laboratory of Optical Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, People’s Republic of China; 7College of Physics and Optoelectronics, South China University of Technology, Guangzhou, People’s Republic of China; 8School of Chemistry and Biochemistry, and School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA; 9Atlantic Veterinary College, Charlottetown, PEI, Canada Radiance spectroscopy was applied to the interstitial detection of localized inclusions containing Au nanocages or nanorods with various concentrations embedded in porcine muscle phantoms. The radiance was quantified using a perturbation approach, which enabled the separation of contributions from the porcine phantom and the localized inclusion, with the inclusion serving as a perturbation probe of photon distributions in the turbid medium. Positioning the inclusion at various places in the phantom allowed for tracking of photons that originated from a light source, passed through the inclusion’s location, and reached a detector. The inclusions with high extinction coefficients were able to absorb nearly all photons in the range of 650–900 nm, leading to a spectrally flat radiance signal. This signal could be converted to the relative density of photons incident on the inclusion. Finally, the experimentally measured quantities were expressed via the relative perturbation and arranged into the classical Beer–Lambert law that allowed one to extract the extinction coefficients of various types of Au nanoparticles in both the transmission and back reflection geometries. It was shown that the spatial variation of perturbation could be described as 1/r dependence, where r is the distance between the inclusion and the detector. Due to a larger absorption cross section, Au nanocages produced greater perturbations than Au nanorods of equal particle concentration, indicating a better suitability of Au nanocages as contrast agents for optical measurements in turbid media. Individual measurements from different inclusions were combined into detectability maps.Keywords: gold nanocages, gold nanorods, turbid media, porcine muscles, diffuse radiance spectroscopy, Beer–Lambert law, perturbation
- 15 January 2015
- Published by Wiley in ChemInform
- Vol. 46 (5)
ChemInform Abstract: Engineered Nanoparticles for Drug Delivery in Cancer Therapy
- 15 January 2015
- Published by Wiley in ChemInform
- Vol. 46 (5)
ChemInform Abstract: Engineered Nanoparticles for Drug Delivery in Cancer Therapy
- Top Cited Papers
- 7 October 2014
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 53 (46) , 12320-12364
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a number of issues associated with conventional therapeutic agents, including their poor water solubility (at least, for most anticancer drugs), lack of targeting capability, nonspecific distribution, systemic toxicity, and low therapeutic index. Over the past several decades, remarkable progress has been made in the development and application of engineered nanoparticles to treat cancer more effectively. For example, therapeutic agents have been integrated with nanoparticles engineered with optimal sizes, shapes, and surface properties to increase their solubility, prolong their circulation half‐life, improve their biodistribution, and reduce their immunogenicity. Nanoparticles and their payloads have also been favorably delivered into tumors by taking advantage of the pathophysiological conditions, such as the enhanced permeability and retention effect, and the spatial variations in the pH value. Additionally, targeting ligands (e.g., small organic molecules, peptides, antibodies, and nucleic acids) have been added to the surface of nanoparticles to specifically target cancerous cells through selective binding to the receptors overexpressed on their surface. Furthermore, it has been demonstrated that multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be delivered through the same carrier to enable combination therapy with a potential to overcome multidrug resistance, and real‐time readout on the treatment efficacy. It is anticipated that precisely engineered nanoparticles will emerge as the next‐generation platform for cancer therapy and many other biomedical applications.
- 7 October 2014
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 53 (46) , 12320-12364
Top Cited PapersEngineered Nanoparticles for Drug Delivery in Cancer Therapy
In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a number of issues associated with conventional therapeutic agents, including their poor water solubility (at least, for most anticancer drugs), lack of targeting capability, nonspecific distribution, systemic toxicity, and low therapeutic index. Over the past several decades, remarkable progress has been made in the development and application of engineered nanoparticles to treat cancer more effectively. For example, therapeutic agents have been integrated with nanoparticles engineered with optimal sizes, shapes, and surface properties to increase their solubility, prolong their circulation half‐life, improve their biodistribution, and reduce their immunogenicity. Nanoparticles and their payloads have also been favorably delivered into tumors by taking advantage of the pathophysiological conditions, such as the enhanced permeability and retention effect, and the spatial variations in the pH value. Additionally, targeting ligands (e.g., small organic molecules, peptides, antibodies, and nucleic acids) have been added to the surface of nanoparticles to specifically target cancerous cells through selective binding to the receptors overexpressed on their surface. Furthermore, it has been demonstrated that multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be delivered through the same carrier to enable combination therapy with a potential to overcome multidrug resistance, and real‐time readout on the treatment efficacy. It is anticipated that precisely engineered nanoparticles will emerge as the next‐generation platform for cancer therapy and many other biomedical applications.